pyrazolanthrone has been researched along with Acute Hepatic Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, L; He, X; Hu, G; Huang, H; Li, S; Liu, X; Ma, R; Meng, J; Peng, Y; Peng, Z; Tang, J; Tao, L; Xie, Y; Yang, H; Yang, X; Zhang, Y | 1 |
| Davis, RJ; Flavell, RA; Frew, J; Henderson, NC; Mackinnon, AC; Pollock, KJ; Sethi, T; Simpson, KJ | 1 |
2 other study(ies) available for pyrazolanthrone and Acute Hepatic Failure
| Article | Year |
|---|---|
Fluorofenidone protects against acute liver failure in mice by regulating MKK4/JNK pathway.
Topics: Acetaminophen; Animals; Anisomycin; Hepatocytes; Lipopolysaccharides; Liver; Liver Failure, Acute; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Necrosis; Pyridones; Reactive Oxygen Species | 2023 |
Critical role of c-jun (NH2) terminal kinase in paracetamol- induced acute liver failure.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Anthracenes; Biopsy; Carbon Tetrachloride; Cell Death; Disease Models, Animal; Drug Administration Schedule; Enzyme Activation; Enzyme Inhibitors; Hepatocytes; Humans; JNK Mitogen-Activated Protein Kinases; Liver; Liver Failure, Acute; Mice; Mice, Inbred C57BL; Mice, Knockout; Tumor Necrosis Factor-alpha | 2007 |